Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity
Authors:
- Quang Van TaQTQuang Van Ta
- Eresha MendisEMEresha Mendis
- Niranjan RajapakseNRNiranjan Rajapakse
- Won-Kyo JungWon-Kyo Jung
- Hee-Guk ByunHBHee-Guk Byun
- You-Jin JeonYJYou-Jin Jeon
- Se-Kwon KimSe-Kwon Kim
- 1 September 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 79 (15) , 1436-1443
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MATRIX METALLOPROTEINASE-2 (MMP-2) AND MMP-9 IN PULMONARY PATHOLOGYExperimental Lung Research, 2005
- Inhibition of HIV-1 Reverse Transcriptase and Protease by Phlorotannins from the Brown Alga Ecklonia cavaBiological and Pharmaceutical Bulletin, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Clinical Trials of a Matrix Metalloproteinase Inhibitor in Human Periodontal DiseaseAnnals of the New York Academy of Sciences, 1999
- Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial MechanismsAdvances in Dental Research, 1998
- Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humansCell and tissue research, 1997
- Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological mediaFEBS Letters, 1996
- Matrix Metalloproteinase-2 Is an Interstitial CollagenaseJournal of Biological Chemistry, 1995
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993
- Anti-plasmin inhibitor. VI. Structure of phlorofucofuroeckol A, a novel phlorotannin with both dibenzo-1,4-dioxin and dibenzofuran elements, from Ecklonia kurome Okamura.Chemical and Pharmaceutical Bulletin, 1990